Back to school on APS: rethinking the risk of recurrent stroke in children.
Fullerton
Heather J
HJ
Von Scheven
Emily
E
D017153:Antibodies, Anticardiolipin / Q000097:blood; D016736:Antiphospholipid Syndrome / Q000097:blood / Q000150:complications* / Q000276:immunology; D002545:Brain Ischemia / Q000097:blood / Q000453:epidemiology / Q000209:etiology / Q000276:immunology; D002648:Child; D015331:Cohort Studies; D015986:Confounding Factors, Epidemiologic; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D002546:Ischemic Attack, Transient / Q000097:blood / Q000453:epidemiology / Q000209:etiology / Q000276:immunology; D015337:Multicenter Studies as Topic; D011446:Prospective Studies; D012008:Recurrence; D012306:Risk; D020521:Stroke / Q000097:blood / Q000453:epidemiology / Q000209:etiology* / Q000276:immunology; D019851:Thrombophilia / Q000097:blood / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology
D017153:Antibodies, Anticardiolipin; D005343:Fibrinolytic Agents